Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Marinus Pharmaceuticals Inc    MRNS

 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
12/11/2017 12/12/2017 12/13/2017 12/14/2017 12/15/2017 Date
7.39(c) 7.37(c) 8.08(c) 9.33(c) 7.89(c) Last
1 243 677 1 070 352 1 885 339 5 472 100 3 583 718 Volume
-5.98% -0.27% +9.63% +15.47% -15.43% Change
More quotes
Financials ($)
Sales 2017 -
EBIT 2017 -20,1 M
Net income 2017 -
Debt 2017 -
Yield 2017 -
Sales 2018 -
EBIT 2018 -41,5 M
Net income 2018 -
Debt 2018 -
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
Capi. / Sales2017 0
Capi. / Sales2018 0
Capitalization 319 M
More Financials
Company
Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of neuropsychiatric therapeutics.Its clinical stage drug candidate, ganaxolone, is a novel synthetic small molecule that is an analog of allopregnanolone, a natural occurring neurosteriod produced by the... 
Sector
Pharmaceuticals
Calendar
03/14Earnings Release
More about the company
Latest news on MARINUS PHARMACEUTICALS IN
12/14 MARINUS PHARMACEUTICALS : Added to NASDAQ Biotechnology Index
12/13 Marinus Pharmaceuticals Added to NASDAQ Biotechnology Index
11/10 MARINUS PHARMACEUTICALS INC : Today’s Research Reports on Stocks to Watch: Marin..
11/01 MARINUS PHARMACEUTICALS,INC. (NASDAQ : MRNS) Files An 8-K Results of Operations ..
10/31 MARINUS PHARMACEUTICALS INC : Results of Operations and Financial Condition, Fin..
10/31 MARINUS PHARMACEUTICALS : Management's Discussion and Analysis of Financial Cond..
10/31 MARINUS PHARMACEUTICALS : posts 3Q loss
10/31 Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2..
09/21 Marinus Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare..
09/20 MARINUS PHARMACEUTICALS : Announces closing of Public Offering of Common Stock a..
More news
Sector news : Pharmaceuticals - NEC
02:06p TEVA PHARMACEUTICAL INDUSTRIES : Strike briefly shuts down Israel over Teva Phar..
12/16 NELSON PELTZ : P&G appoints Peltz to board despite losing proxy battle
12/16 PROCTER & GAMBLE : P&G appoints Peltz to board despite losing proxy battle
12/15 JAZZ PHARMACEUTICALS : Pennsylvania man admits to trading on tips about drug com..
12/15DJSTOCKS TO WATCH : CSX, Aclaris, Alnylam, Rigel
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
12/15 After Hours Gainers / Losers
12/15 Midday Gainers / Losers
12/14 Midday Gainers / Losers
12/14 HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am
12/11 NASDAQ BIOTECH INDEX : 54 to be added, 15 removed
Chart MARINUS PHARMACEUTICALS IN
Duration : Period :
Marinus Pharmaceuticals In Technical Analysis Chart | MRNS | US56854Q1013 | 4-Traders
Technical analysis trends MARINUS PHARMACEUTICALS IN
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Average target price 22,0 $
Spread / Average Target 179%
Managers
NameTitle
Christopher Michael Cashman Chairman, President & Chief Executive Officer
Edward F. Smith Chief Financial Officer, Secretary, Treasurer & VP
Jaakko Lappalainen Vice President-Clinical Development
Lorianne K. Masuoka Chief Medical Officer
Nicole Vitullo Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
MARINUS PHARMACEUTICALS INC823.76%319
JOHNSON & JOHNSON22.95%382 722
PFIZER12.25%221 738
NOVARTIS13.09%221 731
ROCHE HOLDING LTD.3.91%212 270
MERCK AND COMPANY-4.86%153 386